By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Enanta Pharmaceuticals, Inc. 

500 Arsenal Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-607-0800 Fax: 617-607-0530


SEARCH JOBS


Industry
Pharmaceutical






Company News
Enanta Pharmaceuticals, Inc. Release: Company To Host Conference Call On February 8 At 4:30 P.M. ET To Discuss Financial Results For Its Fiscal First Quarter Ended December 31, 2016 1/23/2017 8:07:44 AM
Enanta Pharmaceuticals, Inc. Announces High SVR12 Rates Achieved In Genotype 1 Chronic HCV Infected Japanese Patients With Eight Weeks Of Treatment With Abbvie’s Investigational, Pan-Genotypic, Ribavirin-Free Regimen Of Glecaprevir/Pibrentasvir (G/P) 1/9/2017 1:11:18 PM
FDA Grants Fast Track Designation To Enanta Pharmaceuticals, Inc.’s FXR Agonist Candidate, EDP-305, For The Treatment Of NASH With Liver Fibrosis 1/4/2017 9:40:09 AM
Enanta Pharmaceuticals, Inc. Announces The Appointment Of Dr. Lesley Russell To Its Board Of Directors 11/22/2016 10:42:47 AM
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal Fourth Quarter And Year Ended September 30, 2016 11/22/2016 10:25:22 AM
Enanta Pharmaceuticals, Inc. Announces Abbvie’s Investigational, Pan-Genotypic Regimen Of Glecaprevir/Pibrentasvir (G/P) Shows High SVR Rates In Chronic Hepatitis C Patients With Severe Chronic Kidney Disease 11/15/2016 11:15:20 AM
Enanta Pharmaceuticals, Inc. Announces Eight Weeks Of Treatment With AbbVie (ABBV)’s Investigational, Pan-Genotypic Regimen Of Glecaprevir/Pibrentasvir (G/P) Achieved High SVR Rates Across All Major Genotypes Of Chronic Hepatitis C 11/11/2016 11:48:34 AM
Enanta Pharmaceuticals, Inc. Announces New Data On FXR Agonist EDP-305 For Non-Alcoholic Steatohepatitis (NASH) At The Liver Meeting 2016 11/11/2016 11:44:06 AM
Enanta Pharmaceuticals, Inc. To Host Conference Call On November 21 At 4:30 P.M. ET To Discuss Financial Results For Its Fiscal Fourth Quarter And Year Ended September 30, 2016 11/1/2016 11:53:40 AM
Enanta Pharmaceuticals, Inc. Announces New Data Presentations at The Liver Meeting 2016 10/3/2016 11:19:31 AM
12345678910...
//-->